微RNAs调节动脉样硬化中的功能和临床影响
Zhaoyi Li1, Yidan Zhao1, Sei Suguro2
1State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau SAR, China.
Oxidative medicine and cellular longevity
|September 7, 2023
概括
微RNA通过调节关键细胞过程,在动脉样硬化中起着至关重要的作用. 这些分子显示出作为诊断生物标志物和治疗点的潜力,用于这种广泛的疾病.
科学领域:
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
- 遗传学和表观遗传学
背景情况:
- 动脉样硬化是全球主要的死亡原因,其特征是斑块形成,涉及内皮细胞,血管光滑肌细胞和巨细胞.
- 微RNA (非编码RNA) 是基因表达的关键调节者,影响细胞增殖,细胞亡和新陈代谢.
- 新兴研究强调了microRNAs在动脉样硬化病变发生过程中的重要参与.
研究的目的:
- 审查和总结微RNA在动脉样硬化中的多方面的作用.
- 在动脉样硬化背景下探索微RNA在内皮细胞,血管光滑肌细胞和巨细胞中的功能.
- 评估microRNAs作为动脉样硬化的诊断生物标志物和治疗点的潜力.
主要方法:
- 在2022年6月之前发表的PubMed索引文章的综合文献综述.
- 使用的关键词:"动脉样硬化"",microRNA"",内皮细胞"",血管光滑肌细胞"",巨细胞"和"胆固醇平衡".
- 在动脉样硬化病原体中对微RNA功能的研究结果的综合.
主要成果:
- 在动脉样硬化的不同阶段观察到微RNA表达水平的显著变化.
- 微RNA参与调节内皮功能障碍,斑块稳定性和胆固醇代谢.
- 有证据表明,microRNAs是动脉样硬化发展的核心过程中不可或缺的一部分.
结论:
- 微RNAs代表了动脉样硬化的有希望的新型诊断生物标志物.
- 微RNA显示出作为治疗动脉样硬化管理的治疗标的巨大潜力.
- 对微RNA功能的进一步研究可以推进动脉样硬化治疗策略.
相关概念视频
01:26Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
13
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
13
01:30Atherosclerosis I: Introduction
9
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
9
01:23Atherosclerosis IV: Nursing Management
21
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
21
01:30Coronary Artery Disease I: Introduction
20
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
01:38Inflammation
53.8K
Overview
53.8K